Antibacterial Drugs Market - Global Forecast to 2026, by Drug class (Beta lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, Phenicols, and Others), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
- Report code : CMI6177 |
- Industry :
Pharmaceutical
- Published On : Feb 2019 |
- Pages : 156 Pages |
- Format :
Global Antibacterial Drugs Market – Treatment for Infectious Disease
Antibacterial drugs play a major role in advanced healthcare, as they are majorly used in treatment and prevention of infectious diseases. Antibacterial drugs act by destroying or inhibiting microbial growth.
The global antibacterial drugs market size was valued at US$ 43,791.2 million in 2017, and is expected to exhibit a CAGR of 1.4% over the forecast period (2018 – 2026).
Figure 1. Global Antibacterial Drugs Market Value (US$ Mn), by Region, 2017
Source: Coherent Market Insights Analysis
Increasing incidences of infectious diseases is expected to propel growth of the antibacterial drugs market
Antibacterial drugs are used in treatment of infection caused by various bacteria such as Escherichia coli, Klebsiella pneumonia, and others. Moreover, increasing incidences of infectious diseases such as tuberculosis, hepatitis B, leprosy, typhoid, malaria, HIV/AIDS and others is expected to drive the market growth. According to the World Health Organization (WHO) November 2018 factsheet, an estimated 219 million people were diagnosed by malaria in 2017, in 19 countries.
Moreover, initiatives by government concerned to antibacterial resistance is expected to propel market growth over the forecast period. For instance, in May 2018, the UK government announced fund of US$ 34 million to fight against antimicrobial resistance (AMR). This funding will be distributed to the 4 projects such as Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator of US$ 23 million, Global Antibiotic Research and Development Partnership invested US$ 1 million, and US$ 5 million for two project such as bilateral partnership with Argentina and Foundation for Innovative New Diagnostics.
Figure 2. Global Antibacterial Drugs Market Share (%), by Drug Class, 2018 and 2026
Source: Coherent Market Insights Analysis
Increasing population and high incidences of infectious diseases in North America are expected to bolster the market growth
North America holds dominant position in the global antibacterial drugs market, owing to rising population base susceptible to infectious diseases and higher incidences of infectious diseases such as tuberculosis and others. According to the Centers for Disease Control and Prevention (CDC), in 2017, an estimated 9,105 patients were diagnosed with tuberculosis in the U.S.
Moreover, key players in the market are focused on receiving the U.S. Food and Drug Administration (FDA) approval for novel products to treat patients diagnosed with infectious diseases. For instance, in February 2019, Novartis received the U.S. Food and Drug Administration (FDA) approval for Egaten, used for the treatment of Fascioliasis caused by Fasciola hepatica infection.
Key Players
Major players operating in the global antibacterial drugs market include Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi SA, Bayer AG, and Pfizer Inc.
Antibacterial drugs are used in treatment or prohibition of bacterial infections caused due to various factors such as climatic changes, unhygienic lifestyle specially in emerging economies and others. Major challenge associated with antibacterial drugs is resistance of bacteria towards it. Significant studies are carried out to develop new antibacterial drugs to combat these problems.
Market Dynamics
Increasing prevalence of infectious diseases is a major factor driving antibacterial drugs market growth. According to World Health Organization (WHO), September 2018, annually around 11 million to 21 million cases of typhoid fever are reported worldwide. Moreover, growing geriatric population susceptible to high risk of bacterial infection, majorly caused due to age related changes in immunology is expected to boost the market growth. The Current Opinion in Microbiology Journal 2016, stated Lower respiratory tract infection (Pneumonia), as the most common cause of infection disease in older patients in the U.S. and estimated it as 6 leading cause of death in the U.S.
However, price control of antibacterial drugs, genetic mutation in aging population, and decrease in financial incentives has distracted the focus of pharmaceutical companies from research and development of antibacterial drugs. In September 2016, AstraZeneca announced an agreement with Pfizer to sell the development and commercialization rights to its late-stage small molecule antibiotics business as AstaZeneca does not find antibiotic research as major area for development in their business
Key features of the study:
- This report provides in-depth analysis of the antibacterial drugs market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global antibacterial drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi, Bayer AG, and Pfizer Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
- The global antibacterial drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the antibacterial drugs market
Detailed Segmentation:
- Global Antibacterial Drugs Market, By Drug class:
- Beta lactams
- Quinolones Macrolides
- Tetracycline
- Aminoglycoside
- Sulfonamide
- Phenicols
- Others
- Global Antibacterial Drugs Market, By Route of Administration:
- Oral
- Topical
- Parenteral
- Others
- Global Antibacterial Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Antibacterial Drugs Market, By Geography:
- North America
- By Drug Class:
- Beta lactams
- Quinolones Macrolides
- Tetracycline
- Aminoglycoside
- Sulfonamide
- Phenicols
- Others
- By Route of Administration:
- Oral
- Topical
- Parenteral
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- U.S.
- Canada
- Latin America
- By Drug Class:
- Beta lactams
- Quinolones Macrolides
- Tetracycline
- Aminoglycoside
- Sulfonamide
- Phenicols
- Others
- By Route of Administration:
- Oral
- Topical
- Parenteral
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Drug Class:
- Beta lactams
- Quinolones Macrolides
- Tetracycline
- Aminoglycoside
- Sulfonamide
- Phenicols
- Others
- By Route of Administration:
- Oral
- Topical
- Parenteral
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Drug Class:
- Beta lactams
- Quinolones Macrolides
- Tetracycline
- Aminoglycoside
- Sulfonamide
- Phenicols
- Others
- By Route of Administration:
- Oral
- Topical
- Parenteral
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Drug Class:
- Beta lactams
- Quinolones Macrolides
- Tetracycline
- Aminoglycoside
- Sulfonamide
- Phenicols
- Others
- By Route of Administration:
- Oral
- Topical
- Parenteral
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Drug Class:
- Beta lactams
- Quinolones Macrolides
- Tetracycline
- Aminoglycoside
- Sulfonamide
- Phenicols
- Others
- By Route of Administration:
- Oral
- Topical
- Parenteral
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Novartis AG *
- Company Overview
- Product Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Allergan
- Bristol Myers Squibb Company
- AstraZeneca
- Johnson and Johnson
- Merck & Co., Inc.
- GlaxoSmithKline Plc.
- Sanofi SA
- Bayer AG
- Pfizer Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
- Global Antibacterial Drugs Market, By Drug Class, 2018 – 2026 (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Beta lactams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Quinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Macrolides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Tetracyclines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Aminoglycosides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Sulphonamides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Phenicols
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Global Antibacterial Drugs Market, By Route of Administration, 2018 – 2026 (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Global Antibacterial drugs Market, By Distribution Channel, 2018 – 2026 (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
- Global Antibacterial Drugs Market, By Region, 2018 – 2026 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Novartis AG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Allergan
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bristol Myers Squibb Company
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson and Johnson
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & Co., Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline Plc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi SA
- Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bayer AG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 25 market data tables and 27 figures on "Antibacterial Drugs Market - Global forecast to 2026”.
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.